SCHEMBL148000

SCHEMBL148000

CCCCCCC(C)[PH](=O)[O-].CCCCCCC(C)[PH](=O)[O-].CCCCCCC(C)[PH](=O)[O-].[Nd+3]

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.42
ADH1B P00325 1/20 0.39
ADH1C P00326 1/20 0.39
ADH1A P07327 1/20 0.39
ADH4 P08319 1/20 0.39
ADH7 P40394 1/20 0.39
CA2 P00918 1/20 0.39
OPRM1 P35372 1/20 0.39
ACE2 Q9BYF1 1/20 0.38
GPR84 Q9NQS5 4/20 0.38
FDPS P14324 3/20 0.38
SPHK1 Q9NYA1 1/20 0.38
FFAR1 O14842 1/20 0.38
LMNA P02545 1/20 0.37
MAPT P10636 1/20 0.36
TP53 P04637 1/20 0.36
LCK P06239 1/20 0.36
PPARD Q03181 1/20 0.36
ZDHHC20 Q5W0Z9 1/20 0.36
ZDHHC2 Q9UIJ5 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL672387 0.96 OPRM1 (0.44) CA1ADH1BADH1CADH1AADH4
SCHEMBL639496 0.96 CA1 (0.42) CA1ADH1BADH1CADH1AADH4
SCHEMBL673122 0.96 CA1 (0.42) CA1ADH1BADH1CADH1AADH4
SCHEMBL7155239 0.86 CA2 (0.39) CA1CA2OPRM1FDPS
Phosphonic Acid SCHEMBL23535279 0.78 CA1 (0.42) CA1ADH1BADH1CADH1AADH4
SCHEMBL8677881 0.76 ACE2 (0.44) CA1ADH1BADH1CADH1AADH4
SCHEMBL9875648 0.76 ACE2 (0.44) CA1ADH1BADH1CADH1AADH4
SCHEMBL16335202 0.76 ACE2 (0.44) CA1ADH1BADH1CADH1AADH4
SCHEMBL9875869 0.76 ACE2 (0.44) CA1ADH1BADH1CADH1AADH4
SCHEMBL1568031 0.76 ACE2 (0.44) CA1ADH1BADH1CADH1AADH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 100 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3969490-B1 MODIFIED HIGH-CIS POLYBUTADIENE POLYMER, RELATED METHODS AND TIRE COMPONENTS BRIDGESTONE CORP (JP) 2026-03-25 EP disclosed
US-12565546-B2 Imine group-containing novel compound, modified conjugated diene-based polymer including same, method for preparing the polymer, and rubber composition including the polymer LG CHEM, LTD. (KR) 2026-03-03 US disclosed
US-20260035494-A1 METHOD FOR COLD FLOW REDUCTION OF ELASTOMERS GOODYEAR TIRE & RUBBER (US) 2026-02-05 US disclosed
US-20260001974-A1 DISULFUR DICHLORIDE AND SILANE/SILOXANE ADDITIVE FOR MOONEY JUMP GOODYEAR TIRE & RUBBER (US) 2026-01-01 US disclosed
US-20260002005-A1 DISULFUR DICHLORIDE AND ALKENYL ETHERS ADDITIVES FOR MOONEY JUMP GOODYEAR TIRE & RUBBER (US) 2026-01-01 US disclosed
US-20250389555-A1 MODIFIED HIGH-CIS POLYBUTADIENE POLYMER, RELATED METHODS AND RUBBER COMPOSITIONS BRIDGESTONE AMERICAS TIRE OPERATIONS, LLC (US) 2025-12-25 US disclosed
US-12410263-B2 Modified high-Cis polybutadiene polymer, related methods and rubber compositions BRIDGESTONE AMERICAS TIRE OPERATIONS, LLC (US) 2025-09-09 US disclosed
EP-3883974-B1 POLYMER COMPOSITION AND A METHOD FOR PREPARING THEREOF SIBUR HOLDING PUBLIC JOINT STOCK CO (RU) 2025-09-03 EP disclosed
EP-4032921-B1 METHOD FOR PREPARING MODIFIED CONJUGATED DIENE-BASED POLYMER LG CHEMICAL LTD (KR) 2025-08-27 EP disclosed
US-12371516-B2 Aged lanthanide-based catalyst systems and their use in the preparation of cis-1,4-polydienes BRIDGESTONE CORPORATION (JP) 2025-07-29 US disclosed
WO-2011041534-A1 FUNCTIONALIZED POLYMERS AND METHODS FOR THEIR MANUFACTURE BRIDGESTONE CORPORATION (JP) 2011-04-07 WO disclosed
US-20110077325-A1 FUNCTIONALIZED POLYMERS AND METHODS FOR THEIR MANUFACTURE BRIDGESTONE CORPORATION (JP) 2011-03-31 US disclosed
WO-2011028523-A2 PROCESS AND CATALYST SYSTEM FOR POLYDIENE PRODUCTION BRIDGESTONE CORPORATION (JP) 2011-03-10 WO disclosed
US-7902309-B2 Process and catalyst system for polydiene production BRIDGESTONE CORPORATION (JP) 2011-03-08 US disclosed
US-7879952-B2 Functionalized polymers BRIDGESTONE CORPORATION (JP) 2011-02-01 US disclosed
US-20100317818-A1 POLYMERS FUNCTIONALIZED WITH HALOSILANES CONTAINING AN AMINO GROUP BRIDGESTONE CORPORATION (JP) 2010-12-16 US disclosed
US-7741418-B2 Process for producing polydienes BRIDGESTONE CORPORATION (JP) 2010-06-22 US disclosed
US-20100137520-A1 Branched Polymers and Methods for Their Synthesis and Use BRIDGESTONE CORPORATION (JP) 2010-06-03 US disclosed
US-20090171046-A1 PROCESS FOR PRODUCING POLYDIENES BRIDGESTONE CORPORATION (JP) 2009-07-02 US disclosed
US-20090099325-A1 POLYMERS FUNCTIONALIZED WITH HETEROCYCLIC NITRILE COMPOUNDS BRIDGESTONE CORPORATION 2009-04-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12565546-B2 Imine group-containing novel compound, modified conjugated diene-based polymer including same, method for preparing the polymer, and rubber composition including the polymer CARM1, RIF1, UFM1 CA1 4752/4885ADH1B 3060/4885ADH1C 1256/4885
US-20260035494-A1 METHOD FOR COLD FLOW REDUCTION OF ELASTOMERS ITGA1, HSPA1A, SHC1 CA1 1315/4885ADH1B 3427/4885ADH1C 2206/4885
US-20260001974-A1 DISULFUR DICHLORIDE AND SILANE/SILOXANE ADDITIVE FOR MOONEY JUMP DCLRE1A, DDR1, FDFT1 CA1 1325/4885ADH1B 4146/4885ADH1C 3694/4885
US-20260002005-A1 DISULFUR DICHLORIDE AND ALKENYL ETHERS ADDITIVES FOR MOONEY JUMP MRE11, DDR1, DDB1 CA1 2571/4885ADH1B 4096/4885ADH1C 3880/4885
US-20100317818-A1 POLYMERS FUNCTIONALIZED WITH HALOSILANES CONTAINING AN AMINO GROUP MSN, PARG, ALG1 CA1 1599/4885ADH1B 4367/4885ADH1C 2860/4885
US-20250389555-A1 MODIFIED HIGH-CIS POLYBUTADIENE POLYMER, RELATED METHODS AND RUBBER COMPOSITIONS MALT1, INO80C, RTCB CA1 678/4885ADH1B 1779/4885ADH1C 6/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.